AOYAGI Yoshimi | Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
スポンサーリンク
概要
関連著者
-
Yamazaki Y
Cancer Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Yamada Y
Taiho Pharmaceutical Co. Ltd. Saitama
-
Wierzba Konstanty
東京都医学研究機構東京都臨床医学総合研究所
-
Wierzba Konstanty
東京大学 薬
-
Wierzba Konstanty
Taiho Pharmaceutical Company Hanno Research Center
-
Wierzba Konstanty
Faculty Of Pharmaceutical Sciences University Of Tokyo
-
Wierzba Konstanty
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
YAMADA Yuji
Taiho Pharmaceutical Co. Ltd
-
AOYAGI Yoshimi
Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
-
UTSUGI Teruhiro
Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
-
Aoyagi Yoshimi
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Utsugi T
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Sano Masashi
DIMS Institute of Medical Science, Inc.
-
SHIBATA Masa-Aki
Daiyu-kai Institute of Medical Science
-
Asano T
Department Of Surgery School Of Medicine Teikyo University
-
OKAZAKI Shinji
Cancer Research Laboratory, Hanno Research Center, Taiho Pharmaceutical Company
-
KOBUNAI Takashi
Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
-
AOYAGI Kumio
Taiho Pharmaceutical Co. Ltd., Hanno Research Center
-
ASAO Tetsuji
Taiho Pharmaceutical Co. Ltd., Hanno Research Center
-
OKAZAKI Shinji
Taiho Pharmaceutical Co. Ltd., Hanno Research Center
-
SANO Masaki
Taiho Pharmaceutical Co. Ltd., Hanno Research Center
-
Sano M
Takara Shuzo Co. Ltd. Shiga Jpn
-
Sano Masaki
Cancer Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Asano T
Hanno Research Center Taiho Pharmaceutical Co. Ltd.
-
Asao Tetsuji
Taiho Pharmaceutical Co. Ltd. Research Center
-
Aoyagi Kumio
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Asano Takehide
Department Of Surgery School Of Medicine Teikyo University
-
Okazaki Shinji
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Kobunai Takashi
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Shibata Michiko
Development Strategy Department Yamanouchi Pharmaceutical Co. Ltd.
著作論文
- Establishment and Characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant Cell Lines
- Antitumor Activity of a Novel Quinoline Derivative, TAS-103, with Inhibitory Effects on Topoisomerases I and II